<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To discuss the mechanism of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induced by preoperative chemoradiotherapy and evaluate its effect by detection of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> related proteins in locally advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients who had received preoperative <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: To detect Bcl-XL and Bax expression in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> before and after chemoradiotherapy by EnVision method, combined with patients clinical and pathological index, statistically analysis and evaluation their relationship and clinical significance </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Patients with or without <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage after preoperative chemoradiotherapy was 13 cases and 21 cases </plain></SENT>
<SENT sid="3" pm="."><plain>While the positive rate of Bcl-XL in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> before and after chemoradiotherapy were 58.8% (20/34) and 52.9% (18/34), respectively </plain></SENT>
<SENT sid="4" pm="."><plain>There were significant difference between Bcl-XL change before and after <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells shrinkage and operation pattern </plain></SENT>
<SENT sid="5" pm="."><plain>The positive rate of Bax in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> before and after chemoradiotherapy were 32.4% (11/34) and 44.1% (15/34), respectively </plain></SENT>
<SENT sid="6" pm="."><plain>There were no significant difference between Bax change before and after chemoradiotherapy with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells shrinkage </plain></SENT>
<SENT sid="7" pm="."><plain>There were statistically significant difference between Bax ratio (χ(2) = 9.607, P = 0.048) before and after <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> while there were no significant difference between Bcl-XL/Bax ratio before and after <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage </plain></SENT>
<SENT sid="8" pm="."><plain>According to layered analysis with preoperative therapy, there were statistically significant difference (χ(2) = 13.964, P = 0.007) between Bcl-XL change with operation pattern while the same of significant difference between Bax change with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> infiltration and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> shrinkage (χ(2) = 10.806 and 10.455, both P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Preoperative <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> can influence <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> cell's <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and treatment effect by changing Bcl-XL and Bax expression </plain></SENT>
<SENT sid="10" pm="."><plain>Bcl-XL downregulation and Bax upregulation have shown important function in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> which induced by preoperative <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e>, it can also improve the effection of <z:e sem="disease" ids="C1559154" disease_type="Disease or Syndrome" abbrv="">chemoradiation</z:e> in <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> </plain></SENT>
</text></document>